Reference
Health Canada. Summary Safety Review - Opdivo (nivolumab) - Health Canada. Internet Document : 19 May 2021. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00267
Rights and permissions
About this article
Cite this article
Nivolumab: anaemia and cytokine release and tumour lysis syndromes. Reactions Weekly 1858, 7 (2021). https://doi.org/10.1007/s40278-021-96725-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-96725-4